Welcome to our dedicated page for Regal Rexnord SEC filings (Ticker: RRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Regal Rexnord’s 300-page annual report can feel like a gearbox with too many moving parts—multiple segments, recent integrations, and global supply-chain notes buried in footnotes. If you’ve searched “where can I find Regal Rexnord’s quarterly earnings reports?� or wondered which Form 4 shows the CEO’s latest award, you know the time sink. Stock Titan’s AI-powered analysis opens that casing, turning dense disclosures into clear, concise language.
Inside this hub you’ll see every filing the instant it hits EDGAR—from a Regal Rexnord annual report 10-K simplified to a Regal Rexnord 8-K material events explained alert. Our platform tags each Regal Rexnord insider trading Form 4 transactions entry and highlights segment revenue shifts in the Regal Rexnord quarterly earnings report 10-Q filing. Want the numbers without the jargon? The AI summary sits atop every document, so understanding Regal Rexnord SEC documents with AI takes minutes, not hours.
What really matters for an industrial power-transmission leader? Our filing cards point you straight to:
- Acquisition-synergy costs detailed in 8-Ks
- Backlog trends by Industrial Powertrain and Motion Control in 10-Qs
- Regal Rexnord proxy statement executive compensation tables for governance checks
- Regal Rexnord Form 4 insider transactions real-time via instant alerts
Whether you’re running a Regal Rexnord earnings report filing analysis before an options trade or reviewing Regal Rexnord executive stock transactions Form 4 for sentiment, Stock Titan delivers Regal Rexnord SEC filings explained simply—no mechanical-engineering degree required.
FactSet Research Systems Inc. (FDS) � Form 4 insider transaction
Director James J. McGonigle reported a same-day option exercise and sale on 14 July 2025:
- Options exercised: 2,010 shares at $271.51 and 915 shares at $318.20 (total 2,925 shares) stemming from 2020 and 2021 non-employee director grants.
- Shares sold: 2,925 shares in three open-market lots at weighted average prices of $449.93, $451.05 and $451.98, raising roughly $1.32 million.
- Post-transaction holding: 4,461 common shares held directly—unchanged from the level before the exercise/sale sequence.
The activity represents a routine cashless exercise where all shares obtained from the options were immediately sold. No new shares were added to, or removed from, the director’s long-term stake; therefore, the filing is viewed as neutral from a corporate-governance and liquidity standpoint and immaterial to FDS’s capital structure.